Amino acid residues in the carboxy-terminal region of cottontail rabbit papillomavirus E6 influence spontaneous regression of cutaneous papillomas

Journal of Virology

Volumn 76, Issue 23, 2002, Pages 11801-11808

  Hu, Jiafen ^a   Cladel, Nancy M ^a   Pickel, Martin D ^a   Christensen, Neil D ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHIMERA; CONTROLLED STUDY; IMMUNE RESPONSE; NONHUMAN; ONCOVIRINAE; PAPILLOMA; PRIORITY JOURNAL; REMISSION; VIRUS MUTANT; VIRUS STRAIN; WART VIRUS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CHIMERA; COTTONTAIL RABBIT PAPILLOMAVIRUS; GENES, VIRAL; HUMANS; INBREEDING; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMA; PAPILLOMAVIRUS INFECTIONS; RABBITS; SEQUENCE HOMOLOGY, AMINO ACID; SKIN NEOPLASMS; SPECIES SPECIFICITY; TUMOR VIRUS INFECTIONS;

EID: 0036889352     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.23.11801-11808.2002     Document Type: Article

References (50)

1. Apple, R. J., H. A. Erlich, W. Klitz, M. M. Manos, T. M. Becker, and C. M. Wheeler. 1994. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat. Genet. 6:157-162.
2. Barbosa, M. S., and F. O. Wettstein. 1988. The two proteins encoded by the cottontail rabbit papillomavirus E6 open reading frame differ with respect to localization and phosphorylation. J. Virol. 62:1088-1092.
3. Beekman, N. J., P. A. van Veelen, T. van Hall, A. Neisig, A. Sijts, M. Camps, P. M. Kloetzel, J. J. Neefjes, C. J. Melief, and F. Ossendorp. 2000. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site. J. Immunol. 164:1898-1905.
4. Beskow, A. H., A. M. Josefsson, and U. B. Gyllensten. 2001. HLA class II alleles associated with infection by HPV16 in cervical cancer in situ. Int. J. Cancer 93:817-822.
5. Brandsma, J. L., Z.-H. Yang, D. DiMaio, S. W. Barthold, E. Johnson, and W. Xiao. 1992. The putative E5 open reading frame of cottontail rabbit papillomavirus is dispensable for papilloma formation in domestic rabbits. J. Virol. 66:6204-6207.
6. Breitburd, F., N. Ramoz, J. Salmon, and G. Orth. 1997. HLA control in the progression of human papillomavirus infections. Semin. Cancer Biol. 7:359-371.
7. Chan, S.-Y., L. Ho, C.-K. Ong, V. Chow, B. Drescher, M. Dürst, J. Ter Meulen, L. Villa, J. Luande, H. N. Mgaya, and H.-U. Bernard. 1992. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J. Virol. 66:2057-2066.
8. Christensen, N. D., R. Han, and J. W. Kreider. 2000. Cottontail rabbit papillomavirus (CRPV), p. 485-502. In R. Ahmed and I. Chen (ed.), Persistent Viral Infections. John Wiley & Sons Ltd., Sussex, England.
9. Costello, R. T., J. A. Gastaut, and D. Olive. 1999. Tumor escape from immune surveillance. Arch. Immunol. Ther. Exp. 47:83-88.
10. Evans, C. A., A. L. Rashad, and N. K. Mottet. 1964. The papilloma of rabbits induced by the virus of Shope: Histologic features related to amount of virus in the tumor, p. 587-600. In W. Montagna and W. C. Lobitz, Jr.(ed.), The epidermis. Academic Press, New York, N.Y.
11. Forni, G., P. L. Lollini, P. Musiani, and M. P. Colombo. 2000. Immunoprevention of cancer: Is the time ripe? Cancer Res. 60:2571-2575.
12. Frazer, I. H. 1996. Immunology of papillomavirus infection. Curr. Opin. Immunol. 8:484-491.
13. Friedewald, W. F. 1942. Cell state as affecting susceptibility to a virus; enhanced effectiveness of the rabbit papilloma virus on hyperplastic epidermis. J. Exp. Med. 75:197-220.
14. Garcia-Peydro, M., A. Paradela, J. R. Lamas, and J. A. Lopez De Castro. 1999. Peptide presentation to an alloreactive CTL clone is modulated through multiple mechanisms involving polymorphic and conserved residues in HLA-B27. J. Immunol. 163:6060-6064.
15. Han, R., F. Breitburd, P. N. Marche, and G. Orth. 1992. Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class II genes. Nature 356:66-68.
16. Han, R., N. M. Cladel, C. A. Reed, and N. D. Christensen. 1998. Characterization of transformation function of cottontail rabbit papillomavirus E5 and E8 genes. Virology 251:253-263.
17. Harry, J. B., and F. O. Wettstein. 1996. Transforming properties of the cottontail rabbit papillomavirus oncoproteins LE6 and SE6 and of the E8 protein. J. Virol. 70:3355-3362.
18. Haskill, J. S., M. Key, L. A. Radov, E. Parthenais, J. H. Korn, J. W. Fett, Y. Yamamura, F. DeLustro, J. Vesley, and G. Gant. 1979. The importance of antibody and macrophages in spontaneous and drug-induced regression of the T1699 mammary adenocarcinoma. J. Reticuloendothel. Soc. 26:417-425.
19. Hildesheim, A. 1997. Human papillomavirus variants: Implications for natural history studies and vaccine development efforts. J. Natl. Cancer Inst. 89:752-753.
20. Hildesheim, A., M. Schiffman, C. Bromley, S. Wacholder, R. Herrero, A. Rodriguez, M. C. Bratti, M. E. Sherman, U. Scarpidis, Q. Q. Lin, M. Terai, R. L. Bromley, K. Buetow, R. J. Apple, and R. D. Burk. 2001. Human papillomavirus type 16 variants and risk of cervical cancer. J. Natl. Cancer Inst. 93:315-318.
21. Hoffmann, T. K., N. Meidenbauer, G. Dworacki, H. Kanaya, and T. L. Whiteside. 2000. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. Cancer Res. 60:3542-3549.
22. Hopfl, R., K. Heim, N. Christensen, K. Zumbach, U. Wieland, B. Volgger, A. Widschwendter, S. Haimbuchner, E. Muller-Holzner, M. Pawlita, H. Pfister, and P. Fritsch. 2000. Spontaneous regression of CIN and delayed-type hypersensitivity to HPV-16 oncoprotein E7. Lancet 356:1985-1986.
23. Höpfl, R. M., N. D. Christensen, M. G. Angell, and J. W. Kreider. 1993. Skin test to assess immunity against cottontail rabbit papillomavirus antigens in rabbits with progressing papillomas or after papilloma regression. J. Investig. Dermatol. 101:227-231.
24. Hu, J., R. Han, N. M. Cladel, M. D. Pickel, and N. D. Christensen. 2002. Intracutaneous DNA vaccination with E8 gene of cottontail rabbit papillomavirus induces protective immunity against virus challenge in rabbits. J. Virol. 76:6453-6459
25. Kreider, J. W., N. M. Cladel, S. D. Patrick, P. A. Welsh, S. L. DiAngelo, J. M. Bower, and N. D. Christensen. 1995. High efficiency induction of papillomas in vivo using recombinant cottontail rabbit papillomavirus DNA. J. Virol. Methods 55:233-244.
26. Lin, P., L. A. Koutsky, C. W. Critchlow, R. J. Apple, S. E. Hawes, J. P. Hughes, P. Toure, A. Dembele, and N. B. Kiviat. 2001. HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women. Cancer Epidemiol. Biomark. Prev. 10:1037-1045.
27. Ling, M., M. Kanayama, R. Roden, and T. C. Wu. 2000. Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers. J. Biomed. Sci. 7:341-356.
28. Lowy, D. R., and J. T. Schiller. 1998. Papillomaviruses and cervical cancer: Pathogenesis and vaccine development. J. Natl. Cancer Inst. Monogr. 23:27-30.
29. Maciag, P. C., N. F. Schlecht, P. S. Souza, E. L. Franco, L. L. Villa, and M. L. Petzl-Erler. 2000. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol. Biomark. Prev. 9:1183-1191.
30. Marincola, F. M., E. M. Jaffee, D. J. Hicklin, and S. Ferrone. 2000. Escape of human solid tumors from T-cell recognition: Molecular mechanisms and functional significance. Adv. Immunol. 74:181-273.
31. Meyers, C., J. Harry, Y.-L. Lin, and F. O. Wettstein. 1992. Identification of three transforming proteins encoded by cottontail rabbit papillomavirus. J. Virol. 66:1655-1664.
32. Mocellin, S., E. Wang, and F. M. Marincola. 2001. Cytokines and immune response in the tumor microenvironment. J. Immunother. 24:392-407.
33. Montoya, L., I. Saiz, G. Rey, F. Vela, and N. Clerici-Larradet. 1998. Cervical carcinoma: Human papillomavirus infection and HLA-associated risk factors in the Spanish population. Eur. J. Immunogenet. 25:329-337.
34. Nicholls, P. K., and M. A. Stanley. 2000. The immunology of animal papillomaviruses. Vet. Immunol. Immunopathol. 73:101-127.
35. Okabayashi, M., M. G. Angell, L. R. Budgeon, and J. W. Kreider. 1993. Shope papilloma cell and leukocyte proliferation in regressing and progressing lesions. Am. J. Pathol. 142:489-496.
36. Okabayashi, M., M. G. Angell, N. D. Christensen, and J. W. Kreider. 1991. Morphometric analysis and identification of infiltrating leucocytes in regressing and progressing Shope rabbit papillomas. Int. J. Cancer 49:919-923.
37. Pardoll, D. M. 1998. Cancer vaccines. Nat. Med. 4:525-531.
38. Ronchetti, A., G. Iezzi, M. C. Crosti, M. P. Garancini, M. P. Protti, and M. Bellone. 1999. Role of antigen-presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells. J. Leukoc. Biol. 66:247-251.
39. Salmon, J., M. Nonnenmacher, S. Caze, P. Flamant, O. Croissant, G. Orth, and F. Breitburd. 2000. Variation in the nucleotide sequence of cottontail rabbit papillomavirus a and b subtypes affects wart regression and malignant transformation and level of viral replication in domestic rabbits. J. Virol. 74:10766-10777.
40. Salmon, J., N. Ramoz, P. Cassonnet, G. Orth, and F. Breitburd. 1997. A cottontail rabbit papillomavirus strain (CRPVb) with strikingly divergent E6 and E7 oncoproteins: An insight in the evolution of papillomaviruses. Virology 235:228-234.
41. Schmitt, A., J. B. Harry, B. Rapp, F. O. Wettstein, and T. Iftner. 1994. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. J. Virol. 68:7051-7059.
42. Selvakumar, R., L. A. Borenstein, Y. L. Lin, R. Ahmed, and F. O. Wettstein. 1994. T-cell response to cottontail rabbit papillomavirus structural proteins in infected rabbits. J. Virol. 68:4043-4048.
43. + cells and persistence of viral DNA after regression. J. Virol. 71:5540-5548.
44. + T-regulatory cells and systemic collapse of antitumour immunity. Immunology 103:449-457.
45. Sinkovics, J. G., and J. C. Horvath. 2000. Vaccination against human cancers (review). Int. J. Oncol. 16:81-96.
46. Stoppler, M. C., K. Ching, H. Stoppler, K. Clancy, R. Schlegel, and J. Icenogle. 1996. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J. Virol. 70:6987-6993.
47. Suhrbier, A., S. J. Rodda, P. C. Ho, P. Csurhes, H. Dunckley, A. Saul, H. M. Geysen, and C. M. Rzepczyk. 1991. Role of single amino acids in the recognition of a T cell epitope. J. Immunol. 147:2507-2513.
48. Wu, X., W. Xiao, and J. Brandsma. 1994. Papilloma formation by cottontail rabbit papillomavirus requires E1 and E2 regulatory genes in addition to E6 and E7 transforming genes. J. Virol. 68:6097-6102.
49. Xi, L. F., L. A. Koutsky, D. A. Galloway, J. Kuypers, J. P. Hughes, C. M. Wheeler, K. K. Holmes, and N. B. Kiviat. 1997. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 89:796-802.
50. Zehbe, I., E. Wilander, H. Delius, and M. Tommasino. 1998. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 58:829-833.